Retatrutide appears to be a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By stimulating these https://cormackgcr258792.full-design.com/retatrutide-a-promising-new-treatment-for-obesity-78516990